BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  CREATE Medicines Expands Targeted In Vivo CAR Platform Through Strategic Research Collaboration and Exclusive License Agreement with Monash University

  July 31, 2026

   · 

  4 min read
• Press Releases

  Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate

  July 31, 2026

   · 

  6 min read
• Press Releases

  Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026

  July 31, 2026

   · 

  1 min read
• Press Releases

  Handa Oncology Receives FDA Tentative Approval for OMCAZIO (cabozantinib) Capsules

  July 31, 2026

   · 

  7 min read
• 

  Regulatory

  UniQure welcomes possible adcomm for Huntington’s asset as regulatory ‘jitters’ spread through biopharma

  UniQure is ready to put its Huntington’s disease gene therapy through an advisory committee meeting—even as the broader rare disease space has been put on edge by recent FDA scrutiny of assets by Replimune and Capricor.

  July 31, 2026

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Earnings

  Alnylam absorbs $10.8B blowback after cutting full-year guidance for TTR franchise

  Alnylam’s revenue cut “may create a near term credibility overhang and could “raise questions on peak sales potential, even if there’s tailwinds in the competitive landscape,” according to Stifel.

  July 31, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

  July 31, 2026

   · 

  21 min read
• Press Releases

  SciSparc: Subsidiary NeuroThera Labs’ Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics

  July 31, 2026

   · 

  4 min read
• Press Releases

  Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients

  July 31, 2026

   · 

  12 min read
• Press Releases

  Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026

  July 31, 2026

   · 

  1 min read